BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20669561)

  • 21. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.
    Wautot V; Vercherat C; Lespinasse J; Chambe B; Lenoir GM; Zhang CX; Porchet N; Cordier M; Béroud C; Calender A
    Hum Mutat; 2002 Jul; 20(1):35-47. PubMed ID: 12112656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Medullary thyroid carcinoma and some of its particularities].
    Sidibé el H
    Sante; 2007; 17(1):51-5. PubMed ID: 17897902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotrophic factor receptor RET: structure, cell biology, and inherited diseases.
    Runeberg-Roos P; Saarma M
    Ann Med; 2007; 39(8):572-80. PubMed ID: 17934909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of patients with hereditary medullary thyroid carcinoma.
    Fitze G
    Eur J Pediatr Surg; 2004 Dec; 14(6):375-83. PubMed ID: 15630638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma.
    Marsh DJ; Andrew SD; Eng C; Learoyd DL; Capes AG; Pojer R; Richardson AL; Houghton C; Mulligan LM; Ponder BA; Robinson BG
    Cancer Res; 1996 Mar; 56(6):1241-3. PubMed ID: 8640806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of medullary thyroid carcinoma penetrance suggests the presence of modifier genes in a RET transgenic mouse model.
    Cranston AN; Ponder BA
    Cancer Res; 2003 Aug; 63(16):4777-80. PubMed ID: 12941793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes.
    Ercolino T; Lai R; Giachè V; Melchionda S; Carella M; Delitala A; Mannelli M; Fanciulli G
    Gene; 2014 Feb; 536(2):332-5. PubMed ID: 24361808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain.
    Belar O; De La Hoz C; Pérez-Nanclares G; Castaño L; Gaztambide S;
    Clin Endocrinol (Oxf); 2012 May; 76(5):719-24. PubMed ID: 22026581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma.
    Jimenez C; Dang GT; Schultz PN; El-Naggar A; Shapiro S; Barnes EA; Evans DB; Vassilopoulou-Sellin R; Gagel RF; Cote GJ; Hoff AO
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3521-6. PubMed ID: 15240641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone-secreting tumors: genetic aspects and data from animal models.
    Lytras A; Tolis G
    Neuroendocrinology; 2006; 83(3-4):166-78. PubMed ID: 17047380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and surgical treatment of multiple endocrine neoplasia.
    Zhou GW; Wei Y; Chen X; Jiang XH; Li XY; Ning G; Li HW
    Chin Med J (Engl); 2009 Jul; 122(13):1495-500. PubMed ID: 19719936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common alleles of predisposition in endocrine neoplasia.
    Eng C
    Curr Opin Genet Dev; 2010 Jun; 20(3):251-6. PubMed ID: 20211557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The multiple endocrine neoplasia syndromes.
    Lakhani VT; You YN; Wells SA
    Annu Rev Med; 2007; 58():253-65. PubMed ID: 17037976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial neuroendocrine tumors as a model of hereditary cancer.
    Anderson RJ; Lynch HT
    Curr Opin Oncol; 1997 Jan; 9(1):45-54. PubMed ID: 9090493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multiple endocrine neoplasia].
    Schaaf L; Raue F
    Dtsch Med Wochenschr; 2017 Sep; 142(18):1379-1389. PubMed ID: 28902384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).
    Thakker RV
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):2-15. PubMed ID: 23933118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple endocrine neoplasias.
    Phay JE; Moley JF; Lairmore TC
    Semin Surg Oncol; 2000 Jun; 18(4):324-32. PubMed ID: 10805954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic testing by cancer site: endocrine system.
    Pilarski R; Nagy R
    Cancer J; 2012; 18(4):364-71. PubMed ID: 22846739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.
    Wasserman JD; Tomlinson GE; Druker H; Kamihara J; Kohlmann WK; Kratz CP; Nathanson KL; Pajtler KW; Parareda A; Rednam SP; States LJ; Villani A; Walsh MF; Zelley K; Schiffman JD
    Clin Cancer Res; 2017 Jul; 23(13):e123-e132. PubMed ID: 28674121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidental occurrence of metastatic medullary thyroid carcinoma in a patient with multiple endocrine neoplasia type 1 carrying germline MEN1 and somatic RET mutations.
    Cetani F; Pardi E; Berardi V; Romei C; Marcocci C; Elisei R
    J Surg Oncol; 2017 Dec; 116(8):1197-1199. PubMed ID: 28968916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.